Lisocabtagene maraleucel delivers sustained survival benefits and long-term disease control in relapsed or refractory LBCL.

Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a ...

The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...

The National Cancer Institute and University of Oxford report that oral contraceptive use is not associated with increased ...

New research suggests that certain patients with low-risk thyroid cancer can safely forgo postoperative radioiodine ablation ...

A large, population-based study shows that pregnant women who consume a diet high in foods that promote low-grade ...

A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...

Adding stereotactic ablative radiotherapy (SAbR) to neoadjuvant chemotherapy improves pathologic outcomes for patients ...

A comprehensive meta-analysis of over 4.3 million adults shows e-cigarette use is associated with significantly higher odds ...

Childhood cancer survivors have a lower risk for registered COVID-19 infection but a higher risk for severe COVID-19, ...

Tumor necrosis factor (TNF) inhibitor therapy was effective in reducing the likelihood that psoriasis would progress to ...

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.